- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Danielle Kirkman Discusses the Biological Relationship Between Exercise and Hypertension
Evidence suggests that exercise reduces blood pressure, and some of the mechanisms by which this occurs can include a reduction in salt sensitivity and effects on vascular structure, according to Danielle Kirkman, PhD, assistant professor at Virginia Commonwealth University.
Evidence suggests that exercise reduces blood pressure, and some of the mechanisms by which this occurs can include a reduction in salt sensitivity and effects on vascular structure, according to Danielle Kirkman, PhD, assistant professor at Virginia Commonwealth University.
Transcript
How does exercise affect hypertension, and what are the biological mechanisms?
There’s a wealth of research and a lot of evidence out there to suggest that exercise, particularly aerobic exercise, reduces blood pressure. There are several mechanisms by which this can occur; the biological mechanisms probably relate to a reduction in salt sensitivity, so that’s how much our blood pressure raises after we eat a high-sodium meal. Some data has shown that after an exercise intervention of about 6 months, our blood pressure raises less after a high-sodium meal, so that’s certainly one factor.
Other factors may be a reduction in the activation of the sympathetic nervous system, so this could certainly lead to less vasoconstriction and a blood pressure­­­—lowering effect. In addition to that, we know that exercise certainly has beneficial effects on the vascular structure and function, so this could certainly contribute to reducing hypertension. And then finally, we know that exercise is a potent anti-inflammatory and antioxidant, so by reducing inflammation and reducing oxidative stress, this could slowly lead to a reduction in blood pressure.
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Detail Effects—and Uncertainty—of Drug Pricing Negotiations
May 7th 2024Research into the Inflation Reduction Act evaluated payer concerns, patient and physician behavior, which patients will benefit from the first 10 drugs selected for price negotiation, and the ripple effect into Medicaid at the state level.
Read More
